Paper a day Archives • World Duchenne

Showing all 30 results

#apaperaday: Longitudinal Assessment of Creatine Kinase, Creatine/Creatinine ratio, and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy

Longitudinal Assessment of Creatine Kinase, Creatine/Creatinine ratio, and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy

#apaperaday: Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the mdx Mouse Model for Duchenne Muscular Dystrophy

Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the mdx Mouse Model for Duchenne Muscular Dystrophy

#apaperaday: Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study

Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study

#apaperaday: Macrophage plasticity in Duchenne muscular dystrophy: a nexus of pathological remodelling with therapeutic implications

Macrophage plasticity in Duchenne muscular dystrophy: a nexus of pathological remodelling with therapeutic implications

#apaperaday: Variants in the Sequence of the Probe Hybridization Site May Affect MLPA Performance in Patients with Duchenne/Becker Muscular Dystrophy

Variants in the Sequence of the Probe Hybridization Site May Affect MLPA Performance in Patients with Duchenne/Becker Muscular Dystrophy

#apaperaday: Sharing "Negative" Results in Neuromuscular Research: A Positive Experience

Sharing "Negative" Results in Neuromuscular Research: A Positive Experience

#apaperaday: Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies

Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies

#apaperaday: Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy

Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy

#apaperaday: 263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy

263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment.

#apaperaday: A manifesting female carrier of Duchenne muscular dystrophy: Importance of genetics for the dystrophinopathies

A manifesting female carrier of Duchenne muscular dystrophy: Importance of genetics for the dystrophinopathies

#apaperaday: Accuracy of Non-Invasive Prenatal Testing for Duchenne Muscular Dystrophy in Families at Risk: A Systematic Review

Accuracy of Non-Invasive Prenatal Testing for Duchenne Muscular Dystrophy in Families at Risk: A Systematic Review

#apaperaday: Time to diagnosis of Duchenne muscular dystrophy in Austria and Germany

Time to diagnosis of Duchenne muscular dystrophy in Austria and Germany

#apaperaday: Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy

Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy

#apaperaday: Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology

Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology

#apaperaday: Duchenne Muscular Dystrophy in Kazakhstan: A Journey from Diagnosis to the Treatment, the Biases and Achievements

Duchenne Muscular Dystrophy in Kazakhstan: A Journey from Diagnosis to the Treatment, the Biases and Achievements

#apaperaday: A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable?

A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable?

#apaperaday: What Can RNA-Based Therapy Do for Monogenic Diseases?

What Can RNA-Based Therapy Do for Monogenic Diseases?

#apaperaday: Identification of Biallelic dystrophin gene variants during maternal carrier testing for Becker muscular dystrophy and review of the DMD exon 49–51 deletion phenotype

Identification of Biallelic dystrophin gene variants during maternal carrier testing for Becker muscular dystrophy and review of the DMD exon 49–51 deletion phenotype

#apaperaday: Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy

Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy

#apaperaday: The discovery of the DNA methylation episignature for Duchenne muscular dystrophy

The discovery of the DNA methylation episignature for Duchenne muscular dystrophy

#apaperaday: Racial and ethnic differences in timing of diagnosis and clinical services received in Duchenne Muscular Dystrophy

Racial and ethnic differences in timing of diagnosis and clinical services received in Duchenne Muscular Dystrophy

#apaperaday: Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle

Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle

#apaperaday: Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy

Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy

#apaperaday: Biological and genetic therapies for the treatment of Duchenne muscular dystrophy

Biological and genetic therapies for the treatment of Duchenne muscular dystrophy

#apaperaday: Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy

Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy

#apaperaday: Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis: new splicing events

Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis: new splicing events

#apaperaday: Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy

Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy

#apaperaday: Clinical potential of microdystrophin as a surrogate endpoint

Clinical potential of microdystrophin as a surrogate endpoint

#apaperaday: Brother of Cure Rare Disease CEO Dies in Trial of Duchenne Muscular Dystrophy Therapy

Brother of Cure Rare Disease CEO Dies in Trial of Duchenne Muscular Dystrophy Therapy

#apaperaday: Trabecular Bone Volume Is Reduced, With Deteriorated Microstructure, With Aging in a Rat Model of Duchenne Muscular Dystrophy

Trabecular Bone Volume Is Reduced, With Deteriorated Microstructure, With Aging in a Rat Model of Duchenne Muscular Dystrophy

Go back to all news

Sections

Results

News